On September 3, 2019 Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, reported that an overview of the company’s business strategy and development-stage programs will be given at two upcoming conferences being held in New York on September 10th and September 11th (Press release, Spectrum Pharmaceuticals, SEP 3, 2019, View Source [SID1234539201]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Rodman & Renshaw 21st Annual Global Investment Conference, Sponsored by H.C. Wainwright
When: Tuesday, September 10, 2019 at 9:10 AM ET
Morgan Stanley 17th Annual Global Healthcare Conference
When: Wednesday, September 11, 2019 at 1:35 PM ET
The presentations will be webcast live and may be accessed by visiting Spectrum’s website at View Source